TIMOTHY M SHANNON Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for TIMOTHY M SHANNON.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of TIMOTHY M SHANNON. TIMOTHY M SHANNON is EVP and CMO in CURAGEN CORP ($CRGN) and Senior VP and CMO in CURAGEN CORP ($CRGN) and in CytomX Therapeutics, Inc. ($CTMX) and Director in CytomX Therapeutics, Inc. ($CTMX) and Director in ARVINAS INC. ($ARVN) and Director in NextCure, Inc. ($NXTC) and Director in IDEAYA Biosciences, Inc. ($IDYA).
Latest Insider Trading Transactions of TIMOTHY M SHANNON
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ARVN, CRGN, CTMX, IDYA, NXTC
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 19 2020 | ARVN | ARVINAS, INC. | SHANNON TIMOTHY M | Director | Buy | P | 30.26 | 2,000 | 60,520 | 79,546 | 77.5 K to 79.5 K (+2.58 %) |
Jun 18 2020 | IDYA | IDEAYA Biosciences ... | SHANNON TIMOTHY M | Director | Option Exercise | A | 12.84 | 11,000 | 141,240 | 11,000 | |
Jun 04 2020 | ARVN | ARVINAS, INC. | SHANNON TIMOTHY M | Director | Option Exercise | A | 33.57 | 12,000 | 402,840 | 12,000 | |
Jun 04 2020 | ARVN | ARVINAS, INC. | SHANNON TIMOTHY M | Director | Buy | P | 32.30 | 3,000 | 96,900 | 77,546 | 74.5 K to 77.5 K (+4.02 %) |
May 26 2020 | ARVN | ARVINAS, INC. | SHANNON TIMOTHY M | Director | Option Exercise | M | 22.06 | 12,923 | 285,081 | 0 | |
May 26 2020 | ARVN | ARVINAS, INC. | SHANNON TIMOTHY M | Director | Buy | M | 22.06 | 12,923 | 285,081 | 74,546 | 61.6 K to 74.5 K (+20.97 %) |
Mar 23 2020 | ARVN | ARVINAS, INC. | SHANNON TIMOTHY M | Director | Buy | P | 40.00 | 2,500 | 100,000 | 61,623 | 59.1 K to 61.6 K (+4.23 %) |
Dec 19 2019 | IDYA | IDEAYA Biosciences ... | SHANNON TIMOTHY M | Director | Option Exercise | A | 9.15 | 11,000 | 100,650 | 11,000 | |
Jun 17 2019 | NXTC | NextCure, Inc. | SHANNON TIMOTHY M | Director | Option Exercise | A | 15.57 | 22,000 | 342,540 | 22,000 | |
May 28 2019 | ARVN | ARVINAS, INC. | SHANNON TIMOTHY M | Director | Option Exercise | A | 22.06 | 12,923 | 285,081 | 12,923 | |
May 28 2019 | IDYA | IDEAYA Biosciences ... | SHANNON TIMOTHY M | Director | Option Exercise | C | 0.00 | 602,549 | 0 | 0 | |
May 28 2019 | IDYA | IDEAYA Biosciences ... | SHANNON TIMOTHY M | Director | Option Exercise | C | 0.00 | 1,658,164 | 0 | 0 | |
May 28 2019 | IDYA | IDEAYA Biosciences ... | SHANNON TIMOTHY M | Director | Buy | P | 10.00 | 400,000 | 4,000,000 | 2,660,713 | 2.3 M to 2.7 M (+17.69 %) |
May 28 2019 | IDYA | IDEAYA Biosciences ... | SHANNON TIMOTHY M | Director | Buy | C | 0.00 | 602,549 | 0 | 2,260,713 | 1.7 M to 2.3 M (+36.34 %) |
May 28 2019 | IDYA | IDEAYA Biosciences ... | SHANNON TIMOTHY M | Director | Buy | C | 0.00 | 1,658,164 | 0 | 1,658,164 | 0 to 1.7 M |
May 13 2019 | NXTC | NextCure, Inc. | SHANNON TIMOTHY M | Director | Option Exercise | C | 0.00 | 2,296,605 | 0 | 0 | |
May 13 2019 | NXTC | NextCure, Inc. | SHANNON TIMOTHY M | Director | Option Exercise | C | 0.00 | 5,861,455 | 0 | 0 | |
May 13 2019 | NXTC | NextCure, Inc. | SHANNON TIMOTHY M | Director | Option Exercise | C | 0.00 | 5,970,000 | 0 | 0 | |
May 13 2019 | NXTC | NextCure, Inc. | SHANNON TIMOTHY M | Director | Option Exercise | C | 0.00 | 3,582,000 | 0 | 0 | |
May 13 2019 | NXTC | NextCure, Inc. | SHANNON TIMOTHY M | Director | Buy | P | 15.00 | 50,000 | 750,000 | 2,254,442 | 2.2 M to 2.3 M (+2.27 %) |
May 13 2019 | NXTC | NextCure, Inc. | SHANNON TIMOTHY M | Director | Buy | C | 0.00 | 285,867 | 0 | 2,204,442 | 1.9 M to 2.2 M (+14.90 %) |
May 13 2019 | NXTC | NextCure, Inc. | SHANNON TIMOTHY M | Director | Buy | C | 0.00 | 729,599 | 0 | 1,918,575 | 1.2 M to 1.9 M (+61.36 %) |
May 13 2019 | NXTC | NextCure, Inc. | SHANNON TIMOTHY M | Director | Buy | C | 0.00 | 743,110 | 0 | 1,188,976 | 445.9 K to 1.2 M (+166.67 %) |
May 13 2019 | NXTC | NextCure, Inc. | SHANNON TIMOTHY M | Director | Buy | C | 0.00 | 445,866 | 0 | 445,866 | 0 to 445.9 K |
Apr 01 2019 | ARVN | ARVINAS, INC. | SHANNON TIMOTHY M | Director | Buy | P | 14.69 | 3,500 | 51,410 | 58,898 | 55.4 K to 58.9 K (+6.32 %) |
Oct 03 2018 | ARVN | ARVINAS INC. | SHANNON TIMOTHY M | Director | Option Exercise | C | 0.00 | 2,209,833 | 0 | 0 | |
Oct 03 2018 | ARVN | ARVINAS INC. | SHANNON TIMOTHY M | Director | Option Exercise | C | 0.00 | 4,462,837 | 0 | 0 | |
Oct 03 2018 | ARVN | ARVINAS INC. | SHANNON TIMOTHY M | Director | Option Exercise | C | 0.00 | 9,543,387 | 0 | 0 | |
Oct 03 2018 | ARVN | ARVINAS INC. | SHANNON TIMOTHY M | Director | Buy | C | 0.00 | 4,989,554 | 0 | 4,989,554 | 0 to 5 M |
Oct 03 2018 | ARVN | ARVINAS INC. | SHANNON TIMOTHY M | Director | Buy | P | 16.00 | 4,000 | 64,000 | 55,398 | 51.4 K to 55.4 K (+7.78 %) |
Dec 01 2016 | CTMX | CytomX Therapeutic ... | SHANNON TIMOTHY M | Director | Sell | S | 11.18 | 22,086 | 247,008 | 3,244,381 | 3.3 M to 3.2 M (-0.68 %) |
Nov 28 2016 | CTMX | CytomX Therapeutic ... | SHANNON TIMOTHY M | Director | Sell | S | 11.33 | 20,840 | 236,142 | 3,666,467 | 3.7 M to 3.7 M (-0.57 %) |
Nov 28 2016 | CTMX | CytomX Therapeutic ... | SHANNON TIMOTHY M | Director | Sell | S | 11.79 | 6,729 | 79,341 | 3,687,307 | 3.7 M to 3.7 M (-0.18 %) |
Nov 28 2016 | CTMX | CytomX Therapeutic ... | SHANNON TIMOTHY M | Director | Sell | S | 11.84 | 10,890 | 128,921 | 3,694,036 | 3.7 M to 3.7 M (-0.29 %) |
Nov 22 2016 | CTMX | CytomX Therapeutic ... | SHANNON TIMOTHY M | Director | Sell | S | 11.71 | 42,550 | 498,078 | 3,704,926 | 3.7 M to 3.7 M (-1.14 %) |
Nov 21 2016 | CTMX | CytomX Therapeutic ... | SHANNON TIMOTHY M | Director | Sell | S | 11.72 | 13,548 | 158,785 | 3,747,476 | 3.8 M to 3.7 M (-0.36 %) |
Nov 21 2016 | CTMX | CytomX Therapeutic ... | SHANNON TIMOTHY M | Director | Sell | S | 11.64 | 12,805 | 149,085 | 3,761,024 | 3.8 M to 3.8 M (-0.34 %) |
Nov 21 2016 | CTMX | CytomX Therapeutic ... | SHANNON TIMOTHY M | Director | Sell | S | 11.50 | 18,971 | 218,218 | 3,773,829 | 3.8 M to 3.8 M (-0.50 %) |
Nov 16 2016 | CTMX | CytomX Therapeutic ... | SHANNON TIMOTHY M | Director | Sell | S | 11.55 | 18,517 | 213,953 | 3,792,800 | 3.8 M to 3.8 M (-0.49 %) |
Nov 16 2016 | CTMX | CytomX Therapeutic ... | SHANNON TIMOTHY M | Director | Sell | S | 11.48 | 33,064 | 379,476 | 3,811,317 | 3.8 M to 3.8 M (-0.86 %) |
Nov 14 2016 | CTMX | CytomX Therapeutic ... | SHANNON TIMOTHY M | Director | Sell | S | 11.21 | 23,744 | 266,056 | 3,844,381 | 3.9 M to 3.8 M (-0.61 %) |
Nov 14 2016 | CTMX | CytomX Therapeutic ... | SHANNON TIMOTHY M | Director | Sell | S | 11.20 | 35,391 | 396,461 | 3,868,125 | 3.9 M to 3.9 M (-0.91 %) |
Nov 14 2016 | CTMX | CytomX Therapeutic ... | SHANNON TIMOTHY M | Director | Sell | S | 11.07 | 27,135 | 300,390 | 3,903,516 | 3.9 M to 3.9 M (-0.69 %) |
Nov 10 2016 | CTMX | CytomX Therapeutic ... | SHANNON TIMOTHY M | Director | Sell | S | 11.03 | 13,730 | 151,498 | 3,930,651 | 3.9 M to 3.9 M (-0.35 %) |
Jun 14 2016 | CTMX | CytomX Therapeutic ... | SHANNON TIMOTHY M | Option Exercise | A | 10.17 | 14,000 | 142,380 | 14,000 | ||
Jun 10 2016 | CTMX | CytomX Therapeutic ... | SHANNON TIMOTHY M | Director | Sell | S | 10.01 | 2,700 | 27,027 | 4,244,381 | 4.2 M to 4.2 M (-0.06 %) |
Jun 10 2016 | CTMX | CytomX Therapeutic ... | SHANNON TIMOTHY M | Director | Sell | S | 10.06 | 22,842 | 229,791 | 4,247,081 | 4.3 M to 4.2 M (-0.53 %) |
Jun 10 2016 | CTMX | CytomX Therapeutic ... | SHANNON TIMOTHY M | Director | Sell | S | 10.08 | 22,885 | 230,681 | 4,269,923 | 4.3 M to 4.3 M (-0.53 %) |
Jun 08 2016 | CTMX | CytomX Therapeutic ... | SHANNON TIMOTHY M | Director | Sell | S | 10.03 | 9,731 | 97,602 | 4,292,808 | 4.3 M to 4.3 M (-0.23 %) |
Jun 08 2016 | CTMX | CytomX Therapeutic ... | SHANNON TIMOTHY M | Director | Sell | S | 10.01 | 101,767 | 1,018,688 | 4,302,539 | 4.4 M to 4.3 M (-2.31 %) |
Jun 06 2016 | CTMX | CytomX Therapeutic ... | SHANNON TIMOTHY M | Director | Sell | S | 10.83 | 18,428 | 199,575 | 4,404,306 | 4.4 M to 4.4 M (-0.42 %) |
Jun 06 2016 | CTMX | CytomX Therapeutic ... | SHANNON TIMOTHY M | Director | Sell | S | 10.79 | 41,193 | 444,472 | 4,422,734 | 4.5 M to 4.4 M (-0.92 %) |
Jun 02 2016 | CTMX | CytomX Therapeutic ... | SHANNON TIMOTHY M | Director | Sell | S | 10.75 | 22,463 | 241,477 | 4,463,927 | 4.5 M to 4.5 M (-0.50 %) |
Jun 01 2016 | CTMX | CytomX Therapeutic ... | SHANNON TIMOTHY M | Director | Sell | S | 10.60 | 25,082 | 265,869 | 4,486,390 | 4.5 M to 4.5 M (-0.56 %) |
May 27 2016 | CTMX | CytomX Therapeutic ... | SHANNON TIMOTHY M | Director | Sell | S | 10.43 | 39,887 | 416,021 | 4,511,472 | 4.6 M to 4.5 M (-0.88 %) |
May 27 2016 | CTMX | CytomX Therapeutic ... | SHANNON TIMOTHY M | Director | Sell | S | 10.02 | 11,456 | 114,789 | 4,551,359 | 4.6 M to 4.6 M (-0.25 %) |
May 25 2016 | CTMX | CytomX Therapeutic ... | SHANNON TIMOTHY M | Sell | S | 10.00 | 1,200 | 12,000 | 4,562,815 | 4.6 M to 4.6 M (-0.03 %) | |
May 25 2016 | CTMX | CytomX Therapeutic ... | SHANNON TIMOTHY M | Sell | S | 10.10 | 12,053 | 121,735 | 4,564,015 | 4.6 M to 4.6 M (-0.26 %) | |
May 23 2016 | CTMX | CytomX Therapeutic ... | SHANNON TIMOTHY M | Sell | S | 10.09 | 6,187 | 62,427 | 4,576,068 | 4.6 M to 4.6 M (-0.14 %) | |
May 23 2016 | CTMX | CytomX Therapeutic ... | SHANNON TIMOTHY M | Sell | S | 10.14 | 2,500 | 25,350 | 4,582,255 | 4.6 M to 4.6 M (-0.05 %) | |
Oct 16 2015 | CTMX | CytomX Therapeutic ... | SHANNON TIMOTHY M | Director | Option Exercise | C | 0.00 | 1,318,418 | 0 | 0 | |
Oct 16 2015 | CTMX | CytomX Therapeutic ... | SHANNON TIMOTHY M | Director | Option Exercise | C | 0.00 | 3,566,337 | 0 | 0 | |
Oct 16 2015 | CTMX | CytomX Therapeutic ... | SHANNON TIMOTHY M | Director | Buy | C | 0.00 | 1,318,418 | 0 | 1,318,418 | 0 to 1.3 M |
Oct 16 2015 | CTMX | CytomX Therapeutic ... | SHANNON TIMOTHY M | Director | Buy | C | 0.00 | 3,566,337 | 0 | 3,566,337 | 0 to 3.6 M |
May 06 2005 | CRGN | CURAGEN CORP | SHANNON TIMOTHY M | EVP and CMO | Grant | A | 0.00 | 200,000 | 0 | 204,547 | 4.5 K to 204.5 K (+4,398.50 %) |
Jan 28 2005 | CRGN | CURAGEN CORP | SHANNON TIMOTHY M | EVP and CMO | Option Exercise | A | 5.97 | 63,000 | 376,110 | 63,000 | |
Jan 30 2004 | CRGN | CURAGEN CORP | SHANNON TIMOTHY M | Senior VP and CMO | Option Exercise | A | 8.71 | 57,000 | 496,470 | 57,000 |
Page: 1